Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104555983> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2104555983 abstract "The preferred treatment for ventricular fibrillation (VF) refractory to maximal electrical defibrillation remains controversial, as evidenced by recent changes in the American Heart Association's treatment algorithm. To date there have been no published studies conclusively proving one mode of therapy to be superior to another. There is, however, an abundance of animal and clinical data suggesting that bretylium tosylate (BT) is the drug of choice in this setting. In animal studies BT has been shown to lower the canine defibrillation threshold, to facilitate conversion of hypothermia-induced ventricular fibrillation, and to effect spontaneous defibrillation. In 15 years of clinical use as a drug of last resort, and more recently as a first-line drug, BT has developed an impressive track record. Most of the clinical reports are uncontrolled and/or retrospective, but they share a central theme: BT is effective in the treatment of VF refractory to standard therapy. Several small studies have reported successful conversion of VF to a stable rhythm with BT after failure of standard electrical and pharmacologic therapy. Recent studies suggest that earlier use of BT may be associated with improved outcome. Finally, as in animal studies, spontaneous defibrillation has been reported. It is important to note that no drug currently used in the treatment of countershock-refractory VF has been proven effective. The use of some of these drugs is based on tradition rather than scientific evidence. The bulk of currently available scientific data indicates that BT is superior to other commonly used antiarrhythmics in the treatment of VF resistant to countershock.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W2104555983 created "2016-06-24" @default.
- W2104555983 creator A5013026388 @default.
- W2104555983 date "1984-09-01" @default.
- W2104555983 modified "2023-09-26" @default.
- W2104555983 title "Antifibrillatory drugs: The case for bretylium tosylate" @default.
- W2104555983 cites W1969645365 @default.
- W2104555983 cites W1981315471 @default.
- W2104555983 cites W1990976076 @default.
- W2104555983 cites W2014284187 @default.
- W2104555983 cites W2016484664 @default.
- W2104555983 cites W2025184967 @default.
- W2104555983 cites W2034180491 @default.
- W2104555983 cites W2037727790 @default.
- W2104555983 cites W2041423180 @default.
- W2104555983 cites W2045079063 @default.
- W2104555983 cites W2049907563 @default.
- W2104555983 cites W2057898378 @default.
- W2104555983 cites W2058544312 @default.
- W2104555983 cites W2076057152 @default.
- W2104555983 cites W2086934019 @default.
- W2104555983 cites W2091950443 @default.
- W2104555983 cites W2093940037 @default.
- W2104555983 cites W2100010332 @default.
- W2104555983 cites W2126024817 @default.
- W2104555983 cites W2126979067 @default.
- W2104555983 cites W2144829374 @default.
- W2104555983 cites W2166341418 @default.
- W2104555983 cites W3024720320 @default.
- W2104555983 doi "https://doi.org/10.1016/s0196-0644(84)80443-6" @default.
- W2104555983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6476547" @default.
- W2104555983 hasPublicationYear "1984" @default.
- W2104555983 type Work @default.
- W2104555983 sameAs 2104555983 @default.
- W2104555983 citedByCount "3" @default.
- W2104555983 crossrefType "journal-article" @default.
- W2104555983 hasAuthorship W2104555983A5013026388 @default.
- W2104555983 hasConcept C121332964 @default.
- W2104555983 hasConcept C126322002 @default.
- W2104555983 hasConcept C142424586 @default.
- W2104555983 hasConcept C158453852 @default.
- W2104555983 hasConcept C164705383 @default.
- W2104555983 hasConcept C170493617 @default.
- W2104555983 hasConcept C177713679 @default.
- W2104555983 hasConcept C2777795826 @default.
- W2104555983 hasConcept C2779117456 @default.
- W2104555983 hasConcept C2780035454 @default.
- W2104555983 hasConcept C2781005686 @default.
- W2104555983 hasConcept C70616116 @default.
- W2104555983 hasConcept C71924100 @default.
- W2104555983 hasConcept C87355193 @default.
- W2104555983 hasConcept C98274493 @default.
- W2104555983 hasConceptScore W2104555983C121332964 @default.
- W2104555983 hasConceptScore W2104555983C126322002 @default.
- W2104555983 hasConceptScore W2104555983C142424586 @default.
- W2104555983 hasConceptScore W2104555983C158453852 @default.
- W2104555983 hasConceptScore W2104555983C164705383 @default.
- W2104555983 hasConceptScore W2104555983C170493617 @default.
- W2104555983 hasConceptScore W2104555983C177713679 @default.
- W2104555983 hasConceptScore W2104555983C2777795826 @default.
- W2104555983 hasConceptScore W2104555983C2779117456 @default.
- W2104555983 hasConceptScore W2104555983C2780035454 @default.
- W2104555983 hasConceptScore W2104555983C2781005686 @default.
- W2104555983 hasConceptScore W2104555983C70616116 @default.
- W2104555983 hasConceptScore W2104555983C71924100 @default.
- W2104555983 hasConceptScore W2104555983C87355193 @default.
- W2104555983 hasConceptScore W2104555983C98274493 @default.
- W2104555983 hasLocation W21045559831 @default.
- W2104555983 hasLocation W21045559832 @default.
- W2104555983 hasOpenAccess W2104555983 @default.
- W2104555983 hasPrimaryLocation W21045559831 @default.
- W2104555983 hasRelatedWork W1486164344 @default.
- W2104555983 hasRelatedWork W1973821203 @default.
- W2104555983 hasRelatedWork W2028084080 @default.
- W2104555983 hasRelatedWork W2104555983 @default.
- W2104555983 hasRelatedWork W2169626927 @default.
- W2104555983 hasRelatedWork W2420699576 @default.
- W2104555983 hasRelatedWork W2751460022 @default.
- W2104555983 hasRelatedWork W2979981789 @default.
- W2104555983 hasRelatedWork W3037768552 @default.
- W2104555983 hasRelatedWork W373378315 @default.
- W2104555983 isParatext "false" @default.
- W2104555983 isRetracted "false" @default.
- W2104555983 magId "2104555983" @default.
- W2104555983 workType "article" @default.